Page 3 - Dennism Lanfear News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dennism lanfear. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dennism Lanfear Today - Breaking & Trending Today

HC Wainwright Reaffirms Buy Rating for Coherus BioSciences (NASDAQ:CHRS)

Coherus BioSciences (NASDAQ:CHRS – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a research report issued on Wednesday, Benzinga reports. They presently have a $13.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 496.33% from the company’s current […] ....

United States , Dennism Lanfear , Coherus Biosciences , Robertw Baird , Coherus Biosciences Company Profile , Hermes Inc , Dorsey Whitney Trust , Maxim Group , Coherus Biosciences Inc , Eagle Bay Advisors , Princeton Global Asset Management , Get Free Report , Bay Advisors , Financial Advisors , Global Asset Management , Whitney Trust , Federated Hermes , Coherus Biosciences Daily , Nasdaq Chrs , Reiterated Rating , Hc Wainwright ,

Coherus BioSciences, Inc. (NASDAQ:CHRS) Shares Sold by Citigroup Inc.

Citigroup Inc. lowered its position in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 41.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 508,103 shares of the biotechnology company’s stock after selling 361,210 shares during the quarter. Citigroup Inc. owned 0.54% […] ....

New York , United States , Coherus Biosciences , Dennism Lanfear , Alphacentric Advisors , Worldwide Group Holding , York Life Investment Management , Exchange Commission , Coherus Biosciences Inc , Citigroup Inc , Phocas Financial Corp , Jump Financial , Free Report , Centric Advisors , Get Free Report , Coherus Biosciences Daily , Nasdaq Chrs , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Coherus BioSciences, Inc. (NASDAQ:CHRS) Short Interest Up 9.3% in May

Coherus BioSciences, Inc. (NASDAQ:CHRS – Get Rating) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 13,010,000 shares, an increase of 9.3% from the May 15th total of 11,900,000 shares. Based on an average daily volume of 1,990,000 shares, the short-interest ratio is […] ....

Dennism Lanfear , Alan Herman , Steve Glover , Doug Farrar , Coherus Biosciences , Maxim Group , Coherus Biosciences Inc , Metlife Investment Management , Coherus Biosciences Company Profile , Commonwealth Of Pennsylvania Public School Empls Retrmt , Blackrock Inc , Get Rating , Life Investment Management , Pennsylvania Public School Empls Retrmt , Redwood City , Coherus Biosciences Daily , Nasdaq Chrs ,

Coherus BioSciences, Inc. (NASDAQ:CHRS) Short Interest Up 12.9% in May

Coherus BioSciences, Inc. (NASDAQ:CHRS – Get Rating) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 11,900,000 shares, an increase of 12.9% from the April 30th total of 10,540,000 shares. Based on an average daily trading volume, of 1,550,000 shares, the short-interest ratio […] ....

Steve Glover , Doug Farrar , Alan Herman , Dennism Lanfear , Coherus Biosciences , Hermes Inc , Verition Fund Management , Eagle Bay Advisors , Coherus Biosciences Inc , Get Rating , Financial Advisors , Bay Advisors , Forest Capital Management , Biosciences Trading Down , Redwood City , Coherus Biosciences Daily , Nasdaq Chrs ,

Short Interest in Coherus BioSciences, Inc. (NASDAQ:CHRS) Increases By 12.9%

Coherus BioSciences, Inc. (NASDAQ:CHRS – Get Rating) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 11,900,000 shares, a growth of 12.9% from the April 30th total of 10,540,000 shares. Based on an average daily trading volume, of 1,550,000 shares, the days-to-cover ratio […] ....

Dennism Lanfear , Coherus Biosciences , Steve Glover , Alan Herman , Doug Farrar , Vanguard Group Inc , Aristotle Capital Boston , Blackrock Inc , Coherus Biosciences Inc , Get Rating , Street Corp , Capital Boston , Redwood City , Coherus Biosciences Daily , Nasdaq Chrs ,